|
1
|
Dikbas I, Tanalp J, Tomruk CO and Koksal
T: Evaluation of reasons for extraction of crowned teeth: a
prospective study at a university clinic. Acta Odontol Scand.
71:848–856. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kobayashi Y, Udagawa N and Takahashi N:
Action of RANKL and OPG for osteoclastogenesis. Crit Rev Eukaryot
Gene Expr. 19:61–72. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boyce BF and Xing L: Functions of
RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem
Biophys. 473:139–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seo BM, Miura M, Gronthos S, et al:
Investigation of multipotent postnatal stem cells from human
periodontal ligament. Lancet. 364:149–155. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gronthos S, Mrozik K, Shi S and Bartold
PM: Ovine periodontal ligament stem cells: isolation,
characterization, and differentiation potential. Calcif Tissue Int.
79:310–317. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wada N, Maeda H, Tanabe K, et al:
Periodontal ligament cells secrete the factor that inhibits
osteoclastic differentiation and function: the factor is
osteoprotegerin/osteoclastogenesis inhibitory factor. J Periodontal
Res. 36:56–63. 2001. View Article : Google Scholar
|
|
7
|
Hasegawa T, Yoshimura Y, Kikuiri T, et al:
Expression of receptor activator of NF-kappa B ligand and
osteoprotegerin in culture of human periodontal ligament cells. J
Periodontal Res. 37:405–411. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kanzaki H, Chiba M, Shimizu Y and Mitani
H: Dual regulation of osteoclast differentiation by periodontal
ligament cells through RANKL stimulation and OPG inhibition. J Dent
Res. 80:887–891. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fan JJ, Cao LG, Wu T, et al: The
dose-effect of icariin on the proliferation and osteogenic
differentiation of human bone mesenchymal stem cells. Molecules.
16:10123–10133. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hsieh TP, Sheu SY, Sun JS and Chen MH:
Icariin inhibits osteoclast differentiation and bone resorption by
suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.
Phytomedicine. 18:176–185. 2011.PubMed/NCBI
|
|
11
|
Ma HP, Ming LG, Ge BF, et al: Icariin is
more potent than genistein in promoting osteoblast differentiation
and mineralization in vitro. J Cell Biochem. 112:916–923. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cao H, Ke Y, Zhang Y, Zhang CJ, Qian W and
Zhang GL: Icariin stimulates MC3T3-E1 cell proliferation and
differentiation through up-regulation of bone morphogenetic
protein-2. Int J Mol Med. 29:435–439. 2012.PubMed/NCBI
|
|
13
|
Mok SK, Chen WF, Lai WP, et al: Icariin
protects against bone loss induced by oestrogen deficiency and
activates oestrogen receptor-dependent osteoblastic functions in
UMR 106 cells. Br J Pharmacol. 159:939–949. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nian H, Ma MH, Nian SS and Xu LL:
Antiosteoporotic activity of icariin in ovariectomized rats.
Phytomedicine. 16:320–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao J, Ohba S, Komiyama Y, Shinkai M,
Chung UI and Nagamune T: Icariin: a potential osteoinductive
compound for bone tissue engineering. Tissue Eng Part A.
16:233–243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen KM, Ge BF, Ma HP, Liu XY, Bai MH and
Wang Y: Icariin, a flavonoid from the herb Epimedium enhances the
osteogenic differentiation of rat primary bone marrow stromal
cells. Pharmazie. 60:939–942. 2005.PubMed/NCBI
|
|
17
|
Yin XX, Chen ZQ, Liu ZJ, Ma QJ and Dang
GT: Icariine stimulates proliferation and differentiation of human
osteoblasts by increasing production of bone morphogenetic protein
2. Chin Med J (Engl). 120:204–210. 2007.PubMed/NCBI
|
|
18
|
Mogi M, Otogoto J, Ota N and Togari A:
Differential expression of RANKL and osteoprotegerin in gingival
crevicular fluid of patients with periodontitis. J Dent Res.
83:166–169. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sakata M, Shiba H, Komatsuzawa H, et al:
Expression of osteoprotegerin (osteoclastogenesis inhibitory
factor) in cultures of human dental mesenchymal cells and
epithelial cells. J Bone Miner Res. 14:1486–1492. 1999. View Article : Google Scholar
|
|
20
|
Hasegawa T, Yoshimura Y, Kikuiri T, et al:
Expression of receptor activator of NF-kappa B ligand and
osteoprotegerin in culture of human periodontal ligament cells. J
Periodontal Res. 37:405–411. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dong SW, Ying DJ, Duan XJ, et al: Bone
regeneration using an acellular extracellular matrix and bone
marrow mesenchymal stem cells expressing Cbfa1. Biosci Biotechnol
Biochem. 73:2226–2233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ducy P: Cbfa1: a molecular switch in
osteoblast biology. Dev Dyn. 219:461–471. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lian JB, Stein JL, Stein GS, et al:
Runx2/Cbfa1 functions: diverse regulation of gene transcription by
chromatin remodeling and co-regulatory protein interactions.
Connect Tissue Res. 44(Suppl 1): 141–148. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Patterson-Buckendahl P: Osteocalcin is a
stress-responsive neuropeptide. Endocr Regul. 45:99–110. 2011.
View Article : Google Scholar
|
|
25
|
Maïmoun L, Fattal C and Sultan C: Bone
remodeling and calcium homeostasis in patients with spinal cord
injury: a review. Metabolism. 60:1655–1663. 2011.PubMed/NCBI
|
|
26
|
Hsieh TP, Sheu SY, Sun JS, Chen MH and Liu
MH: Icariin isolated from Epimedium pubescens regulates osteoblasts
anabolism through BMP-2, SMAD4, and Cbfa1 expression.
Phytomedicine. 17:414–423. 2010. View Article : Google Scholar : PubMed/NCBI
|
